skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: tipo de recurso: Newsletter Articles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
"Related Formulations And Methods Related To Eye Irritation" in Patent Application Approval Process
"Related Formulations And Methods Related To Eye Irritation" in Patent Application Approval Process
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

"Related Formulations And Methods Related To Eye Irritation" in Patent Application Approval Process

Veterinary Research Week, 2024, p.5312

NewsRX LLC

Texto completo disponível

Citações Citado por
2
New Data from Polytechnic University Torino Illuminate Research in Photogrammetry Remote Sensing and Spatial Information Sciences
New Data from Polytechnic University Torino Illuminate Research in Photogrammetry Remote Sensing and Spatial Information Sciences
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

New Data from Polytechnic University Torino Illuminate Research in Photogrammetry Remote Sensing and Spatial Information Sciences

Science Letter, 2024, p.377-377

NewsRX LLC

Texto completo disponível

Citações Citado por
3
"Formulations And Methods Related To Eye Irritation And Related" in Patent Application Approval Process
"Formulations And Methods Related To Eye Irritation And Related" in Patent Application Approval Process
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

"Formulations And Methods Related To Eye Irritation And Related" in Patent Application Approval Process

Veterinary Week, 2023, p.4684

NewsRX LLC

Texto completo disponível

Citações Citado por
4
Patent Application Titled "Novel compounds for treatment of diseases related to DUX4 expression" Published Online (USPTO 20230271953)
Patent Application Titled "Novel compounds for treatment of diseases related to DUX4 expression" Published Online (USPTO 20230271953)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Patent Application Titled "Novel compounds for treatment of diseases related to DUX4 expression" Published Online (USPTO 20230271953)

Cancer Weekly, 2023, p.713

NewsRX LLC

Texto completo disponível

Citações Citado por
5
Reports Outline Archaeology Study Findings from University of Florence [Mortar Characterization of Historical Masonry Damaged by Riverbank Failure: The Case of Lungarno Torrigiani ]
Reports Outline Archaeology Study Findings from University of Florence [Mortar Characterization of Historical Masonry Damaged by Riverbank Failure: The Case of Lungarno Torrigiani ]
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Reports Outline Archaeology Study Findings from University of Florence [Mortar Characterization of Historical Masonry Damaged by Riverbank Failure: The Case of Lungarno Torrigiani ]

Science Letter, 2023, p.685-685

NewsRX LLC

Texto completo disponível

Citações Citado por
6
Department of Pharmacological and Biomolecular Sciences Researchers Detail Findings in Hypercholesterolemia
Department of Pharmacological and Biomolecular Sciences Researchers Detail Findings in Hypercholesterolemia
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Department of Pharmacological and Biomolecular Sciences Researchers Detail Findings in Hypercholesterolemia

Health & Medicine Week, 2023, p.1585

NewsRX LLC

Texto completo disponível

Citações Citado por
7
"New compounds for treatment of diseases related to DUX4 expression" in Patent Application Approval Process (USPTO 20230052017)
"New compounds for treatment of diseases related to DUX4 expression" in Patent Application Approval Process (USPTO 20230052017)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

"New compounds for treatment of diseases related to DUX4 expression" in Patent Application Approval Process (USPTO 20230052017)

Cancer Weekly, 2023, p.317

NewsRX LLC

Texto completo disponível

Citações Citado por
8
Patent Issued for Stable and soluble antibodies inhibiting TNFa (USPTO 11578123)
Patent Issued for Stable and soluble antibodies inhibiting TNFa (USPTO 11578123)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Patent Issued for Stable and soluble antibodies inhibiting TNFa (USPTO 11578123)

Hepatitis Weekly, 2023, p.1037

NewsRX LLC

Texto completo disponível

Citações Citado por
9
Study Findings from Universidad Privada del Norte Broaden Understanding of Psychology (Cross-national measurement invariance of the Purpose in Life Test in seven Latin American countries)
Study Findings from Universidad Privada del Norte Broaden Understanding of Psychology (Cross-national measurement invariance of the Purpose in Life Test in seven Latin American countries)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Study Findings from Universidad Privada del Norte Broaden Understanding of Psychology (Cross-national measurement invariance of the Purpose in Life Test in seven Latin American countries)

Psychology & Psychiatry Journal, 2022, p.327

NewsRX LLC

Texto completo disponível

Citações Citado por
10
Researchers from National Council for Science and Technology Report on Findings in Extracellular Matrix Proteins
Researchers from National Council for Science and Technology Report on Findings in Extracellular Matrix Proteins
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Researchers from National Council for Science and Technology Report on Findings in Extracellular Matrix Proteins

Life Science Weekly, 2022, p.2909

NewsRX LLC

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2012  (12)
  2. 2012Até2014  (40)
  3. 2015Até2017  (84)
  4. 2018Até2021  (66)
  5. Após 2021  (13)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.